Folqué M, Lozano J, Riggioni C, et al. ‘Real-life’ experience in asthmatic children treated with omalizumab up to six-years follow-up. Allergol Immunopathol. 2019;47(4):336-341. Accessed April 26, 2026. https://www.all-imm.com/index.php/aei/article/view/299